Results 201 to 210 of about 2,102,666 (322)
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Evolution Landscape of PiggyBac (PB) Transposon in Beetles (Coleoptera). [PDF]
Wang Q +6 more
europepmc +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Material Properties, Characterization, and Application of Microcellular Injection-Molded Polypropylene Reinforced with Oyster Shells for Pb(II) Adsorption Kinetics from Aqueous Solutions. [PDF]
Chien M +5 more
europepmc +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Metal Pollution in the Air and Its Effects on Vulnerable Populations: A Narrative Review. [PDF]
Gonzalez-Villalva A +15 more
europepmc +1 more source
The management of basic sanitation in the city of Campina Grande – PB: a look at the years 2007 to 2020 [PDF]
Wilton Maia Velez
openalex
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Pinocembrin as a novel anti-cancer agent: Exploring preclinical evidence along with therapeutic potential. [PDF]
Singla N +11 more
europepmc +1 more source

